SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-283551
Filing Date
2022-11-14
Accepted
2022-11-14 06:21:04
Documents
14
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d412095d8k.htm   iXBRL 8-K 25495
2 EX-99.1 d412095dex991.htm EX-99.1 59497
6 GRAPHIC g412095g1114011404937.jpg GRAPHIC 2236
  Complete submission text file 0001193125-22-283551.txt   223519

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rain-20221110.xsd EX-101.SCH 2852
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rain-20221110_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rain-20221110_pre.xml EX-101.PRE 11705
8 EXTRACTED XBRL INSTANCE DOCUMENT d412095d8k_htm.xml XML 3465
Mailing Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560
Business Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560 (510) 953-5559
Rain Therapeutics Inc. (Filer) CIK: 0001724979 (see all company filings)

IRS No.: 821130967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40356 | Film No.: 221379777
SIC: 2834 Pharmaceutical Preparations